Gamfexine
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H27N |
| Molar mass | 245.410 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Gamfexine (WIN-1,344) is a centrally acting stimulant drug, which was tested as an adjunct treatment for withdrawn patients with schizophrenia, but while effective for treating withdrawal it made psychotic symptoms worse.[1]
It was stated that gamfexine was the progenitor in the discovery of venlafaxine.[2] This could be the reason why both agents share the same suffix.
Synthesis
[edit]The precursor chemical is made from benzyl cyanide and bromocyclohexane.[3] This compound serves dual use in the synthesis of drofenine, hexasonium & feclemine.
The synthesis of gamfexine has been discussed:[4][5] Patents:[6][7] The method discussed by Lednicer & Mitscher is slightly different from the patented procedure and uses 2-Cyclohexylidene-2-phenylacetonitrile [10461-98-0].[8] This chemical is an odoriferous substance. It is known to have been used in the synthesis of Fenclexonium.
Alkylation of cyclohexylphenylacetonitrile [3893-23-0] (1) with 2-chloroethyldimethylamine (2), using NaNH2 as base, gives nitrile, PC412902 (3). Removal of the nitrile group apparently occurred upon reaction with more NaNH2. This completed the synthesis of Gamfexine (4).
N.B. Note that the removal of cyanide also occurs in one of the syntheses of chlorpheniramine. Here though, sulfuric acid was used as the reagent for this step.
An alternative synthesis strategy is envisioned to consist of Mannich reaction & organometallic addition to the carbonyl group (c.f. trihexyphenidyl), followed by reductive removal of the tertiary hydroxyl group; or by starting form Benzoylcyclohexane [712-50-5].
See also
[edit]- Delucemine
- 3,3-Diphenyl-N-dimethylpropylamine [4646-55-3] is reported to have antidepressant properties.[9] It is made from diphenylmethane.[10]
References
[edit]- ^ Biel JH (January 1967). "Antidepressants, Stimulants, Hallucinogens". Annual Reports in Medicinal Chemistry. 2. Academic Press: 11–23 (18). doi:10.1016/S0065-7743(08)61499-2.
- ^ Yardley, J. P.; Husbands, G. E. M.; Stack, G.; Butch, J.; Bicksler, J.; Moyer, J. A.; Muth, E. A.; Andree, T.; Fletcher h, H.; James, M. N. (1990). "2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity". Journal of Medicinal Chemistry 33 (10): 2899–2905. doi:10.1021/jm00172a035. PMID 1976813.
- ^ "a-CYCLOHEXYLPHENYLACETONITRILE". Organic Syntheses. 25: 25. 1945. doi:10.15227/orgsyn.025.0025.
- ^ Ruddy, A. Wayne (1951). "Antispasmodics. II. Substituted α-(β-Aminoethyl)-phenylacetonitriles and 3-Phenylpropylamines". Journal of the American Chemical Society. 73 (9): 4096–4098. doi:10.1021/ja01153a013.
- ^ The organic chemistry of drug synthesis, volume 2, Daniel Lednicer & Lester Mitscher (page 56).
- ^ Mario D Aceto, Louis S Harris, Alexander Ernest John, Alonzo M Lands, U.S. patent 3,328,249 (1967 to Sterling Drug Inc).
- ^ Mario D Aceto, et al. U.S. patent 3,485,873 (1969 to STWB Inc).
- ^ Eyal BEN-ARI, WO2018207191 (to Agan Aroma and Fine Chemicals Ltd).
- ^ Geraint Jones, U.S. patent 3,446,901 (1969 to Ed Geistlich Soehne AG fuer Chemische Industrie).
- ^ John W. Cusic, U.S. patent 2,534,239 (1950 to G. D. Searle & Co.).
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |